| Predicate |
Object |
| contentType |
Comment|Letter|Multicenter Study|Randomized Controlled Trial |
| endingPage |
7 |
| issn |
0140-6736 |
| issueIdentifier |
9599 |
| pageRange |
1606; author reply 1606-7 |
| publicationName |
Lancet (London, England) |
| startingPage |
1606; author reply 1606 |
| bibliographicCitation |
Mihas C, Alevizos A, Arapaki A, Mariolis A. Warfarin versus aspirin for stroke prevention (BAFTA). Lancet. 2007 Nov 10;370(9599):1606; author reply 1606–7. doi: 10.1016/s0140-6736(07)61679-1. PMID: 17993356. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcf73ea5c0549da1d9f0f4772bd1381d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebeddf021a451c8e873430c32b082943
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75f8568290745f449469871cc801f0e1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a0633d7476d2634d15f51ca3c79f59d |
| date |
2007-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/17993356
https://doi.org/10.1016/s0140-6736%2807%2961679-1 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0140-6736
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Warfarin versus aspirin for stroke prevention (BAFTA) |
| discusses |
http://id.nlm.nih.gov/mesh/M0001380
http://id.nlm.nih.gov/mesh/M0022871 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D019934Q000592
http://id.nlm.nih.gov/mesh/D000925Q000627
http://id.nlm.nih.gov/mesh/D020521Q000517
http://id.nlm.nih.gov/mesh/D014859Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D000925Q000097
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D014859Q000097 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54678486 |